Announcements Trials
Browse Landscape Eligibility

Clinical Trials

2 trials
RecentStart dateEnrollment
Acids × Clear all

Phase

Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Peritoneal Neoplasms 1Hepatitis B, Chronic 1Hepatitis B 1Heartburn 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 2848Cisplatin 2837Carboplatin 2635Radiotherapy 2522Paclitaxel 2424Gemcitabine 2263pembrolizumab 2099Docetaxel 1978Bevacizumab 1966Fluorouracil 1660Capecitabine 1640Oxaliplatin 1551Dexamethasone 1417Nivolumab 1394Doxorubicin 1349Rituximab 1338Magnetic Resonance Spectroscopy 1229Etoposide 1198Irinotecan 1122Leucovorin 1096Drug Therapy 1062Cytarabine 1010Pemetrexed 944fludarabine 933Specimen Handling 875Vincristine 857Prednisone 851Lenalidomide 838Trastuzumab 837Cetuximab 831

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT02151448 2020-07-20

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

University of Pittsburgh

Phase 1/2 Completed
64 enrolled 18 charts
Gynecologic

Peritoneal Neoplasms

NCT04301908 2020-03-10

A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis

Beijing Ditan Hospital

Unknown
10,000 enrolled
Gastrointestinal

Heartburn, Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡